EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deep learning for adaptive chemotherapy: A DDPG-based approach to optimizing tumor-immune dynamics

Wenlang Zhu, Mingliu Zhu, Weiye Wang, Liang Xu, Jie Wu, Weiping Li, Ruru Ma, Lingli Cao iD

PLOS One · 08.04.2026 · 21 (4) · e0345877

DOI: 10.1371/journal.pone.0345877 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 08.04.2026. Verfasst von Wenlang Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, The First People's Hospital of Taicang City, Taicang Affiliated Hospital of Soochow University, Taicang, Jian…. Hauptthemen laut MEDLINE: Deep Learning, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this article, we propose a deep reinforcement learning based chemotherapy regulation framework to realize personalized and dynamic optimization of cancer treatment. We use a nonlinear dynamic system to model the dynamic evolution of the tumor microenvironment including tumor cell, normal cell and immune cell interactions, with drug concentration serving as the control input variable. The Deep Deterministic Policy Gradient (DDPG) algorithm makes agents can study optimal dosing strategy in a continuous space of movement to inhibit tumor growth effectively and minimize damage to normal tissues. To make the strategy more stable, Gauss noise is added to the model to simulate physiological oscillations and uncertainties in the treatment reaction. Experimental results show that it can control the growth of tumor in various initial scenarios and the accumulation of the drug concentration with high flexibility and safety. Our technique provides a feasible technical way for precision, low toxicity adaptive chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep LearningNeoplasmsAntineoplastic AgentsHumansTumor MicroenvironmentReinforcement Machine LearningAlgorithmsAdaptive AlgorithmsNonlinear Dynamics

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Gastrointestinal Surgery, The First People's Hospital of Taicang City, Taicang Affiliated Hospital of Soochow University, Taicang, Jiangsu, China.
  • School of Mathematical Sciences, Suzhou University of Science and Technology, Suzhou, China.
  • School of Artificial Intelligence and Computer Science, Jiangnan University, Wuxi, China.
  • Department of Obstetrics and Gynecology, The First People's Hospital of Taicang City, Taicang Affiliated Hospital of Soochow University, Taicang, Jiangsu, China.

ORCID-Profile: Lingli Cao

Förderung

  • the National Natural Science Foundation of China

Zitieren

APA

Zhu, W., Zhu, M., Wang, W., Xu, L., Wu, J., Li, W., Ma, R., & Cao, L. (2026). Deep learning for adaptive chemotherapy: A DDPG-based approach to optimizing tumor-immune dynamics. PLOS One, 21(4), e0345877. https://doi.org/10.1371/journal.pone.0345877

Vancouver

Zhu W, Zhu M, Wang W, Xu L, Wu J, Li W, et al. Deep learning for adaptive chemotherapy: A DDPG-based approach to optimizing tumor-immune dynamics. PLOS One. 2026;21(4):e0345877. doi:10.1371/journal.pone.0345877

BibTeX
@article{Zhu2026,
  author = {Zhu, Wenlang and Zhu, Mingliu and Wang, Weiye and Xu, Liang and Wu, Jie and Li, Weiping and Ma, Ruru and Cao, Lingli},
  title = {Deep learning for adaptive chemotherapy: A DDPG-based approach to optimizing tumor-immune dynamics},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {4},
  pages = {e0345877},
  doi = {10.1371/journal.pone.0345877}
}
Kostenlos starten →